Physician profile
Hemil Maniar
NPI 1972924488
$5,319.42
in general payments reported to CMS, 2019-2025
15 companies · $1,972 in 2025
The $1,972 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.07 · 2020: $105 · 2021: $121 · 2022: $227 · 2023: $2,757 · 2024: $108 · 2025: $1,972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,776 · Food and Beverage: $1,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,776.07 |
| Food and Beverage | $1,061.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,049.54 | 2023 | Conduit |
| Medtronic, INC. | $1,863.85 | 2025 | Cd Horizon Spinal System, Mazor X System |
| Depuy Synthes Sales INC. | $443.80 | 2023 | Conduit |
| Globus Medical, INC. | $179.63 | 2021-2023 | Excelsiusgps Robotic Navigation System |
| Si-Bone, INC. | $172.37 | 2021-2023 | |
| Acumed LLC | $140.18 | 2023 | Acumed |
| Nuvasive, INC. | $118.89 | 2019-2020 | |
| Stryker Corporation | $117.45 | 2020-2022 | |
| Titan Surgical Group, LLC | $90.35 | 2025 | |
| Orthofix Medical, INC. | $38.80 | 2024 | Cervical-Stim |
| Jazz Pharmaceuticals INC. | $35.75 | 2024 | |
| Theragen, INC. | $18.00 | 2025 | Actastim-S |
| Djo, LLC | $17.43 | 2021 | |
| Genentech USA, INC. | $16.98 | 2024 | Ocrevus Zunovo, Ocrevus |
| Argenx US, INC. | $16.40 | 2024 | Vyvgart Hytrulo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hemil Maniar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.